[Gefitinib for non-small cell lung cancer: a meta analysis].
Guo Jiwu, Ma Bin, Zhou Huiyin, +2 more·Zhongguo fei ai za zhi = Chinese journal of lung cancer
BACKGROUND AND OBJECTIVE: Malignant grade and death rate are very high for non-small cell lung cancer, and gefitinib is a new molecule target anticancer drug. The aim of this meta analysis is to evaluate the clinical efficacy and safety of gefitinib for non-small cell lung cancer. METHODS: We searched the Cochrane Cen…